홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
MBRX
#4445
Moleculin Biotech, Inc.
2.040
0
USD
0.00%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
0.00%
월간 변동
-35.24%
6달 변화
-35.24%
년간 변동율
-35.24%
이전 종가
2.040
0
Open
2.020
0
Bid
2.040
0
Ask
2.043
0
Low
2.005
0
High
2.110
0
양
83
마켓
주식
헬스케어
MBRX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
120.08 K
560.02 K
565.1 K
1.21 M
2.04 M
—
Valuation ratios
Enterprise value
-9.06 M
-3.33 M
-7.17 M
-7.19 M
-5.62 M
-23.31 M
Price to earnings ratio
-0
-0.01
0.01
0.01
-0.01
-0.01
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0
-0.01
-0.01
-0
-0.01
-0.03
Price to book ratio
0
0.04
0
0
0.04
0.08
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.32
0.14
0.31
0.38
1.25
2.07
Return on equity %
0.99
0.38
153.24
1.14
0.94
155.71
Return on invested capital %
241.54
226
203.14
189.17
189.11
807.42
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.08
0.97
1.35
1.15
1.39
4.86
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
41.15
36.91
12.21
8.99
4.84
62.95
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
63.3
31.06
20.64
12.17
4.49
68.37
Net current asset value per share
78.12
37.71
24.99
14.61
5.28
82.6
Tangible book value per share
-24.7
-37.53
-29.71
-6.41
10.57
-63.09
Working capital per share
40.47
-1.2
6.54
1.87
1.48
8.69
Book value per share
50.34
43.41
0.11
11.54
18.04
73.1
뉴스
Moleculin Biotech releases CEO update on leukemia trial
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%
몰레큘린 바이오테크, 워런트 행사 합의 후 급락
Moleculin Biotech stock plunges after warrant exercise agreement
몰레쿨린 바이오테크, warrant 행사로 830만 달러 조달
Moleculin Biotech raises $8.3 million through warrant exercise
몰레큘린 바이오테크, AML 치료제 임상 시험 결과에 주가 상승
Moleculin Biotech stock rises as AML drug trial shows promising results
몰레큘린, AML 치료 임상시험 중간 데이터 긍정적
Moleculin reports promising early data in pivotal AML treatment trial
몰레큘린 바이오테크, 일본 특허 확보 후 주가 상승
Moleculin Biotech stock rises after securing key Japanese patent